X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (245) 245
pd-1 (219) 219
pd‐1 (216) 216
humans (173) 173
immunotherapy (143) 143
cancer (117) 117
oncology (113) 113
t cells (113) 113
apoptosis (101) 101
female (98) 98
immunology (88) 88
lymphocytes (88) 88
male (85) 85
pd-l1 (81) 81
immune checkpoint (73) 73
pd‐l1 (73) 73
animals (72) 72
nivolumab (72) 72
lymphocytes t (68) 68
tumors (66) 66
middle aged (64) 64
analysis (60) 60
cell death (59) 59
adult (58) 58
expression (58) 58
aged (57) 57
melanoma (56) 56
patients (54) 54
care and treatment (52) 52
pembrolizumab (51) 51
ligands (50) 50
mice (50) 50
metastasis (44) 44
t-cells (44) 44
cell biology (42) 42
ipilimumab (42) 42
flow cytometry (41) 41
immune system (40) 40
blockade (39) 39
chemotherapy (38) 38
dendritic cells (38) 38
survival (38) 38
hematology (37) 37
programmed cell death 1 receptor - immunology (37) 37
clinical trials (36) 36
lung cancer (36) 36
activation (34) 34
immunohistochemistry (34) 34
pd-1 protein (34) 34
programmed cell death 1 receptor (34) 34
cd8 antigen (33) 33
cd8-positive t-lymphocytes - immunology (33) 33
ctla-4 (33) 33
medical research (33) 33
safety (33) 33
therapy (32) 32
antibodies (30) 30
antigens (30) 30
cytotoxicity (30) 30
programmed cell death 1 receptor - antagonists & inhibitors (30) 30
programmed cell death 1 receptor - metabolism (30) 30
metastases (29) 29
original (29) 29
prognosis (29) 29
ctla‐4 (28) 28
gene expression (28) 28
pathology (28) 28
programmed death-1 (27) 27
t-lymphocytes - immunology (27) 27
aged, 80 and over (26) 26
b7-h1 antigen (26) 26
health aspects (26) 26
immunity (26) 26
tolerance (26) 26
exhaustion (25) 25
immune response (24) 24
open-label (24) 24
antibodies, monoclonal - therapeutic use (23) 23
b7-h1 (23) 23
b7-h1 antigen - metabolism (23) 23
cancer therapies (23) 23
article (22) 22
b7 family (22) 22
biomarkers (22) 22
cd4 antigen (22) 22
drug therapy (22) 22
medical prognosis (22) 22
pd-l1 protein (22) 22
programmed cell death 1 receptor - genetics (22) 22
autoimmunity (21) 21
cytokines (21) 21
inhibitors (21) 21
mice, inbred c57bl (21) 21
up-regulation (21) 21
anti-pd-1 (20) 20
inflammation (20) 20
lymphocyte activation - immunology (20) 20
proteins (20) 20
surgery (20) 20
antigens, cd - metabolism (19) 19
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Applied Surface Science, ISSN 0169-4332, 01/2019, Volume 465, pp. 172 - 179
This work studies the adsorption properties of Pd(1 1 1) surface to various SF decomposition components (H S, SO , SOF , and SO F ). Due to the affluent active... 
Surface adsorption | Pd(1 1 1) adsorbent | SF6 decomposition components | DFT calculations
Journal Article
Asian Pacific Journal of Cancer Prevention, ISSN 1513-7368, 03/2018, Volume 19, Issue 3, pp. 693 - 698
Background: Positive and negative co-stimulatory molecules are important factors determining the outcome of immune responses to the presence of tumors. Since... 
PD.1 | Colon cancer | ICOS | Polymorphism | polymorphism
Journal Article
Journal Article
EMBO molecular medicine, ISSN 1757-4676, 07/2019, Volume 11, Issue 7, p. e10293
The majority of lung cancer patients progressing from conventional therapies are refractory to PD-L1/PD-1 blockade monotherapy. Here, we show that baseline... 
lung cancer | Immunology | B7‐H1 | immunotherapy | biomarker | PD‐1 | PD‐L1 | Cancer
Journal Article
Journal of Hepato‐Biliary‐Pancreatic Sciences, ISSN 1868-6974, 06/2019, Volume 26, Issue 6, pp. 242 - 243
Highlight Tanaka and Kubo reported the first case of recurrent occupational cholangiocarcinoma treated with programmed death‐1 inhibitor. A programmed death‐1... 
Occupational cholangiocarcinoma | Programmed death‐ligand 1 | PD‐1 inhibitor | CA19‐9 | Nivolumab
Journal Article
Pathologe, ISSN 0172-8113, 11/2018, Volume 39, Issue 6, pp. 546 - 555
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 12/2019, Volume 125, Issue S24, pp. 4616 - 4622
Despite advances in surgery and chemotherapy and the integration of antivascular endothelial growth factor therapy as well as poly(adenosine... 
immunotherapy combinations | antiprogrammed cell death protein 1 (anti‐PD‐1) | ovarian cancer | immunotherapy | antiprogrammed death‐ligand 1 (anti‐PD‐L1) | checkpoint inhibitor
Journal Article
Clinical Case Reports, ISSN 2050-0904, 11/2019, Volume 7, Issue 11, pp. 2156 - 2164
A 60‐year‐old woman with stage IV rectal cancer received adoptive cell therapy with autologous cancer antigen (AC‐ACT) causing induction of anti‐oncogenic and... 
cancer | PD‐1 | adoptive cell therapy | miRNA analysis | immunotherapy
Journal Article